[1]
Tanya Barrett, Dennis B. Troup, Stephen E. Wilhite, Pierre Ledoux, Dmitry Rudnev, et al. NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Research, vol. 35, pp.760-765, (2007).
DOI: 10.1093/nar/gkl887
Google Scholar
[2]
Tanya Barrett, Dennis B. Troup, Stephen E. Wilhite, Pierre Ledoux, Dmitry Rudnev. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Research, Vol. 37, pp.885-890, (2009).
DOI: 10.1093/nar/gkn764
Google Scholar
[3]
Ron Edgar and Tanya Barrett. NCBI GEO standards and services for microarray data. Nat Biotechnol, vol. 24(12), pp.1471-1472, (2006).
DOI: 10.1038/nbt1206-1471
Google Scholar
[4]
Tanya Barrett and Ron Edgar. Gene Expression Omnibus (GEO): Microarray data storage, submission, retrieval, and analysis. Methods Enzymol, vol. 411, pp: 352-369, (2006).
DOI: 10.1016/s0076-6879(06)11019-8
Google Scholar
[5]
Khoi Q. Tran, Deborah A. Swartz-Basile, Attila Nakeeb, and Henry A. Pitt. Gallbladder Motility in Agouti-Yellow and Leptin-Resistant Obese Mice. Journal of Surgical Research, vol. 113, pp: 56-61, (2003).
DOI: 10.1016/s0022-4804(03)00157-4
Google Scholar
[6]
Akio Inui. Feeding and body-weight regulation by hypothalamic neuropeptides-mediation of the actions of leptin. Trends Neurosci, vol. 22, pp: 62-67, (1999).
DOI: 10.1016/s0166-2236(98)01292-2
Google Scholar
[7]
M. Friedman-Einata, L. Camoinb, Z. Faltinc, C.I. Rosenblumd,V. Kalioutaa, et al. Serum leptin activity in obese and lean patients, Regulatory Peptides , vol. 111, pp: 77-82, (2003).
DOI: 10.1016/s0167-0115(02)00259-8
Google Scholar
[8]
Considine RV, Sinha K, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med, vol. 334, pp: 292-295, (1996).
DOI: 10.1056/nejm199602013340503
Google Scholar
[9]
Alexandra Grosfeld, Jocelyne Andre , Sylvie Hauguel-de Mouzon , Edurne Berra, Jacques Pouysse gur , and Michele Guerre-Millo. ypoxia-inducible Factor 1 Transactivates the Human Leptin Gene Promoter. The Journal of Biological Chemistry, vol. 277, p.42953–42957, (2002).
DOI: 10.1074/jbc.m206775200
Google Scholar
[10]
Wang GL, Jiang B-H, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci , vol. 92, pp: 5510-5514, (1995).
DOI: 10.1073/pnas.92.12.5510
Google Scholar
[11]
Jiang B-H, Semenza GL, Bauer C, Marti HH. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol, vol. 271, pp: 1172-1180, (1996).
DOI: 10.1152/ajpcell.1996.271.4.c1172
Google Scholar
[12]
Gregg L Semenza. HIF-1 and mechanisms of hypoxia sensing. Current Opinion in Cell Biology, vol. 13, pp: 167-171, (2001).
DOI: 10.1016/s0955-0674(00)00194-0
Google Scholar
[13]
Jianguo Li, Dmitry N. Grigoryev, Shui Qing Ye, Laura Thorne, Alan R. Schwartz, et al. Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice. J Appl Physio, vol. 99, pp: 1643-1648, (2005).
DOI: 10.1152/japplphysiol.00522.2005
Google Scholar
[14]
Zhao Y and Simon R. BRB ArrayTools Data Archive for Human Cancer Gene Expression: A Unique and Efficient Data Sharing Resource. Cancer Informatics, vol. 6, pp: 9-15, (2008).
DOI: 10.4137/cin.s448
Google Scholar
[15]
Nogales-Cadenas R, Carmona-Saez P, Vazquez M, Vicente C, Yang X, Tirado F, Carazo JM, Pascual-Montano A: GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Research, vol. 37(Web Server issue): W317-22. (2009).
DOI: 10.1093/nar/gkp416
Google Scholar
[16]
Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A: GENECODIS: A web-based tool for finding significant concurrent annotations in gene lists. Genome Biology, 8(1): R3 , (2007).
DOI: 10.1186/gb-2007-8-1-r3
Google Scholar
[17]
Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc, vol4(1), pp: 44-45, (2009).
DOI: 10.1038/nprot.2008.211
Google Scholar
[18]
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol, vol. 4(5), p.3, (2003).
DOI: 10.1186/gb-2003-4-9-r60
Google Scholar
[19]
Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., and Hirakawa, M.; KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res, vol. 38, pp: 355-360, (2010).
DOI: 10.1093/nar/gkp896
Google Scholar
[20]
Kanehisa, M., Goto, S., Hattori, M., Aoki-Kinoshita, K.F., Itoh, M., Kawashima, S., Katayama, T., Araki, M., and Hirakawa, M.; From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res, vol. 34, pp.354-357, (2006).
DOI: 10.1093/nar/gkj102
Google Scholar
[21]
Kanehisa, M. and Goto, S.; KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res, vol. 28, pp: 27-30, (2000).
DOI: 10.1093/nar/28.1.27
Google Scholar
[22]
Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell, vol. 83, pp: 841-850, (1995).
DOI: 10.1016/0092-8674(95)90200-7
Google Scholar
[23]
Timothy M Willson and Walter Wahlit. Peroxisome proliferator-activated receptor agonists. Current Opinion in Chemical Biology, vol. 1, pp: 235-241, (1997).
DOI: 10.1016/s1367-5931(97)80015-4
Google Scholar
[24]
Liang Guo, Reza Tabrizchi. Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance. Pharmacology & Therapeutics, vol. 111, pp: 145 -173, (2006).
DOI: 10.1016/j.pharmthera.2005.10.009
Google Scholar
[25]
P. Escher, W. Wahli. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat. Res, vol. 448, pp: 121-138, (2000).
DOI: 10.1016/s0027-5107(99)00231-6
Google Scholar
[26]
Yajun Zhou, Xin Jia, Mingming Zhou, Jie Liu. Egr-1 is involved in the inhibitory effect of leptin on PPARγ expression in hepatic stellate cell in vitro. Life Sciences, vol. 84 544-551, (2009).
DOI: 10.1016/j.lfs.2009.01.018
Google Scholar
[27]
Alexandra Grosfelda, Sophie Turbana, Jocelyne Andre, Michele Cauzac, et al. Transcriptional eject of hypoxia on placental leptin. FEBS Letters, vol. 502, pp: 122-126, (2001).
DOI: 10.1016/s0014-5793(01)02673-4
Google Scholar
[28]
Sander Kersten. Peroxisome proliferator activated receptors and obesity. European Journal of Pharmacology, vol. 440, pp: 223-234, (2002).
DOI: 10.1016/s0014-2999(02)01431-0
Google Scholar
[29]
Seth S. Martin, Atif Qasim, Muredach P. Reilly. Leptin Resistance: A Possible Interface of Inflammationand Metabolism in Obesity-Related Cardiovascular Disease. Journal of the American College of Cardiology, Vol. 52, pp: 1201-1210, (2008).
DOI: 10.1016/j.jacc.2008.05.060
Google Scholar